Releases
NBY
0.6012
+17.88%
0.0912
  • All
  • Financials
  • Insiders
More
Webull provides the latest Novabay Pharma (NBY) stock and general news. This information may help you make smarter investment decisions.
About NBY
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.